These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2925281)

  • 1. Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin.
    Hofsli E; Nissen-Meyer J
    Int J Cancer; 1989 Mar; 43(3):520-5. PubMed ID: 2925281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.
    Hofsli E; Nissen-Meyer J
    Int J Cancer; 1989 Jul; 44(1):149-54. PubMed ID: 2568347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by lipophilic drugs.
    Hofsli E; Nissen-Meyer J
    Cancer Res; 1990 Jul; 50(13):3997-4002. PubMed ID: 2354448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.
    Wright SC; Tam AW; Kumar P
    Cancer Immunol Immunother; 1992; 34(6):399-406. PubMed ID: 1563018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
    Chang NS
    Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin, vincristine, and actinomycin-D, but not teniposide, require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug-resistant cells.
    Toffoli G; Tumiotto L; Gigante M; Perin T; Biscontin G; Boiocchi M
    Cancer Detect Prev; 1993; 17(3):425-32. PubMed ID: 8402730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor necrosis factor on human tumor cell lines sensitive and resistant to cytotoxic drugs, and its interaction with chemotherapeutic agents.
    Soranzo C; Perego P; Zunino F
    Anticancer Drugs; 1990 Dec; 1(2):157-63. PubMed ID: 2131048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.
    Fan D; Poste G; Seid C; Earnest LE; Bull T; Clyne RK; Fidler IJ
    Invest New Drugs; 1994; 12(3):185-95. PubMed ID: 7896537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs.
    Neale ML; Matthews N
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):133-7. PubMed ID: 2493381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
    Safrit JT; Berek JS; Bonavida B
    Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
    Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
    Schwabe K; Steinheider G; Lawen A; Traber R; Hildebrandt A
    J Cancer Res Clin Oncol; 1995; 121(7):407-12. PubMed ID: 7635870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity.
    Utsugi T; Demuth S; Hanna N
    Cancer Res; 1989 Mar; 49(6):1429-33. PubMed ID: 2538225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
    D'Alessandro N; Flugy A; Tolomeo M; Dusonchet L
    Anticancer Res; 1998; 18(4C):3065-72. PubMed ID: 9713511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
    Morimoto H; Safrit JT; Bonavida B
    J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cytogenetic and cytotoxic effects on multidrug-resistant (MDR) cells by a calcium antagonist (verapamil).
    Nito S
    Mutat Res; 1989 Oct; 227(2):73-9. PubMed ID: 2797045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A; Daly AK; Atherton K; Campbell FC
    Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.